通策医疗
(600763)
| 流通市值:152.85亿 | | | 总市值:152.85亿 |
| 流通股本:4.44亿 | | | 总股本:4.44亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,501,468,689.46 | 1,586,118,351.78 | 755,289,213.29 | 2,913,101,528.81 |
| 营业收入 | 2,501,468,689.46 | 1,586,118,351.78 | 755,289,213.29 | 2,913,101,528.81 |
| 二、营业总成本 | 1,738,959,209.67 | 1,116,871,540.34 | 528,626,816.22 | 2,250,412,202.89 |
| 营业成本 | 1,414,120,786.1 | 904,928,333.29 | 423,913,486.89 | 1,787,821,316.6 |
| 税金及附加 | 4,563,248.37 | 3,874,741.68 | 471,767.78 | 6,289,468.05 |
| 销售费用 | 26,539,302.88 | 16,246,876.48 | 8,336,413.6 | 34,351,540.07 |
| 管理费用 | 221,224,699.89 | 147,387,431.76 | 75,243,505.75 | 319,798,633.81 |
| 研发费用 | 40,973,649.39 | 24,357,247.39 | 12,428,842.04 | 61,227,083.26 |
| 财务费用 | 31,537,523.04 | 20,076,909.74 | 8,232,800.16 | 40,924,161.1 |
| 其中:利息费用 | 27,445,998.88 | 16,331,593.65 | 6,426,838.25 | 35,845,027.22 |
| 其中:利息收入 | 575,176.2 | 535,500.7 | 348,152.51 | 1,958,856.57 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | 898,358.23 |
| 加:投资收益 | 128,415,858.13 | 125,849,531.25 | 8,806,004.91 | 46,432,488.04 |
| 资产处置收益 | 750,672.35 | 548,829.14 | 1,123.48 | -268,751.22 |
| 资产减值损失(新) | - | - | - | -4,236.37 |
| 信用减值损失(新) | 361,745.03 | 657,742.61 | 3,876,212.9 | -11,983,070.21 |
| 其他收益 | 4,593,085.14 | 4,147,812.61 | 2,799,328.33 | 10,247,937.97 |
| 四、营业利润 | 896,630,840.44 | 600,450,727.05 | 242,145,066.69 | 708,012,052.36 |
| 加:营业外收入 | 186,964.04 | 161,762.32 | 44,049.65 | 1,019,133.31 |
| 减:营业外支出 | 3,825,882.84 | 2,373,119.08 | 436,747.74 | 3,675,400.47 |
| 五、利润总额 | 892,991,921.64 | 598,239,370.29 | 241,752,368.6 | 705,355,785.2 |
| 减:所得税费用 | 113,034,859.53 | 77,530,523.57 | 21,172,234.05 | 117,065,814.39 |
| 六、净利润 | 779,957,062.11 | 520,708,846.72 | 220,580,134.55 | 588,289,970.81 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 779,957,062.11 | 520,708,846.72 | 220,580,134.55 | 588,289,970.81 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 669,941,944.51 | 458,411,209.7 | 186,874,603.48 | 501,945,804.29 |
| 少数股东损益 | 110,015,117.6 | 62,297,637.02 | 33,705,531.07 | 86,344,166.52 |
| 扣除非经常损益后的净利润 | 537,263,714.84 | 325,404,857.71 | 184,827,971.65 | 495,889,571.01 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.5 | 1.03 | 0.42 | 1.12 |
| (二)稀释每股收益 | 1.5 | 1.03 | 0.41 | 1.12 |
| 八、其他综合收益 | -1,552,067.28 | -2,409,741.83 | -0.12 | -94,310,428.95 |
| 归属于母公司股东的其他综合收益 | -1,552,067.28 | -2,409,741.83 | -0.12 | -94,310,428.95 |
| 九、综合收益总额 | 778,404,994.83 | 518,299,104.89 | 220,580,134.43 | 493,979,541.86 |
| 归属于母公司股东的综合收益总额 | 668,389,877.23 | 456,001,467.87 | 186,874,603.36 | 407,635,375.34 |
| 归属于少数股东的综合收益总额 | 110,015,117.6 | 62,297,637.02 | 33,705,531.07 | 86,344,166.52 |
| 公告日期 | 2026-10-28 | 2026-08-15 | 2026-04-18 | 2026-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |